Moreover, C646 increased AKT and GSK phosphorylation in the absence of insulin, suggesting that P300 acetyltransferase inhibitors may offer promise for the treatment of type 1 diabetes. This evidence concerns the gene AKT1 and type 1 diabetes mellitus.